Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer

European Archives of Oto-Rhino-Laryngology

Volumn 268, Issue 5, 2011, Pages 721-726

  Snietura, Miroslaw ^a   Piglowski, Wojciech ^a   Jaworska, Magdalena ^a   Mucha Malecka, Anna ^b   Wozniak, Grzegorz ^a   Lange, Dariusz ^a   Suwinski, Rafal ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Accelerated radiotherapy; Head and neck cancer; HPV infection; Postoperative radiotherapy; Randomized clinical trial

Indexed keywords

BETA GLOBIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DNA VIRUS; FEMALE; FOLLOW UP; GENE AMPLIFICATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HYPOPHARYNX CANCER; IMMUNOHISTOCHEMISTRY; IRRADIATION; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; POSTOPERATIVE CONTINUOUS ACCELERATED IRRADIATION; POSTOPERATIVE CONVENTIONAL FRACTIONATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SPECTROPHOTOMETER; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TONSIL CANCER; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79956159129     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-010-1396-7     Document Type: Article

References (15)

1. Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35
2. Ragin CC, Taioli E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121:1813-1820 (Pubitemid 47417302)
3. Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261-269 (Pubitemid 351480538)
4. Vidal L, Gillison LV (2008) Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin N Am 22:1125-1142
5. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467-475 (Pubitemid 40270113)
6. Marur S, D'Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol [Epub ahead of print]
7. Suwinski R, Bankowska-Wozniak M, Majewski W et al (2008) Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer. Radiother Oncol 87:155-163
8. Suwinski R, Jaworska M, Nikiel B et al (2010) Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial. Int J Radiat Oncol Biol Phys 77:438-446
9. Heck JE, Berthiller J, Vaccarella S et al (2010) Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 39:166-181
10. Worden FP, Kumar B, Lee JS et al (2008) Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 26:3138-3146
11. McGovern SL, Williams MD, Weber RS et al (2009) Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: Case report and comparison with Slaughter's model of field cancerization. Head Neck [Epub ahead of print]
12. Han TJ, Lee CH, Yoo CW et al (2009) Synchronous multifocal HPV-related neoplasm involving both the genital tract and the head-and-neck area: a case report of Fanconi anemia. Radiother Oncol 92:138-141
13. Licitra L, Perrone F, Bossi P et al (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24:5630-5636 (Pubitemid 46631302)
14. Reimers N, Kasper HU, Weissenborn SJ et al (2007) Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 120:1731-1738 (Pubitemid 46399359)
15. Hafkamp HC, Speel EJ, Haesevoets A et al (2003) A subset of head and neck squamous cell carcinomas exhibits integration of HPV16/18 DNA and overexpression of p161NK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 107:394-400 (Pubitemid 37266459)